
ALS Community Petitions FDA To Reconsider BrainStorm’s NurOwn, Pointing to Recent Survival Data
The story of BrainStorm Cell Therapeutics’ NurOwn has a new chapter. Last week, several people with amyotrophic lateral sclerosis submitted a Citizens’ Petition to the FDA requesting that the agency approve the stem cell therapy based on “new evidence and …